自身免疫性疾病家族史在IgG4相关性疾病中的潜在影响:一项回顾性队列研究
该回顾性队列研究纳入北京协和医院628例IgG4相关性疾病患者,比较有或无自身免疫性疾病家族史两组的差异。14.8%的患者有自身免疫性疾病家族史,该组发病年龄更早、抗核抗体阳性率更高、Riedel甲状腺炎比例更高,且更易合并其他自身免疫性疾病,提示IgG4相关性疾病可能与其他自身免疫性疾病共享遗传背景。
要点
- 628例IgG4相关性疾病患者中93例(14.8%)有自身免疫性疾病家族史。
- 有家族史组发病年龄更早(50.4±14.8 vs 54.2±12.6岁,p=0.014),抗核抗体阳性率更高(38.9% vs 22.7%,p=0.0277)。
- 有家族史组Riedel甲状腺炎比例更高(10.9% vs 2.4%,p=0.001),更易合并其他自身免疫性疾病(16.1% vs 6.2%,p=0.0238)。
核心结论
- 14.8%的IgG4相关性疾病患者有自身免疫性疾病家族史,有家族史组发病年龄更早且抗核抗体阳性率更高,提示IgG4相关性疾病可能与其他自身免疫性疾病共享遗传背景。
研究设计与样本
- 回顾性队列研究,纳入北京协和医院628例IgG4相关性疾病患者,按有无自身免疫性疾病家族史分为AID阳性组与AID阴性组进行比较,并用Cox回归分析估计风险比(HR)及其95%置信区间(CI)。
主要发现
- 93例(14.8%)IgG4相关性疾病患者有自身免疫性疾病家族史。
- AID阳性组较AID阴性组发病年龄更早(50.4±14.8 vs 54.2±12.6,p=0.014)。
- AID阳性组较AID阴性组抗核抗体(ANA)阳性率更高(38.9% vs 22.7%,p=0.0277)。
- AID阳性组较AID阴性组Riedel甲状腺炎比例更高(10.9% vs 2.4%,p=0.001)。
- AID阳性组较AID阴性组更易合并其他自身免疫性疾病(16.1% vs 6.2%,p=0.0238)。
关键数值与推荐
- Cox分析显示,在AID阳性IgG4相关性疾病患者中,较年轻年龄(HR 0.97,95% CI 0.94至0.99,p=0.0384)和较高的基线外周血嗜酸性粒细胞比例(HR 1.1,95% CI 1.02至1.2,p=0.0199)增加不良预后风险。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Autoimmune comorbidities may be associated with IgG4-related disease (IgG4-RD), here we aimed to determine the correlation of autoimmune diseases (AID) family history and IgG4-RD in a Chinese cohort. METHODS: This retrospective cohort study identified 628 cases of IgG4-RD in Peking Union Medical College Hospital. Patients were classified into two groups, with AID family history group (AID-positive) and without AID family history group (AID-negative). We viewed the potential value of AID family history on IgG4-RD by comparing the differences between the two groups. In addition, Cox regression analysis estimated CIs and HR for IgG4-RD risk. RESULTS: 93 (14.8%) IgG4-RD patients had AID family history. Compared with AID-negative group, baseline data analysis revealed that AID-positive group patients had an earlier age of IgG4-RD onset (50.4±14.8 vs 54.2±12.6, p=0.014*), a higher percentage of antinuclear antibody (ANA) positivity (38.9% vs 22.7%, p=0.0277*) and Riedel thyroiditis (10.9% vs 2.4%, p=0.001*), were prone to comorbid with other AID (16.1% vs 6.2%, p=0.0238*). Cox analysis found that younger age (HR 0.97 (95% CI 0.94 to 0.99), p=0.0384*) and higher proportions of baseline peripheral eosinophils (HR 1.1 (95% CI 1.02 to 1.2), p=0.0199*) increased the risk of unfavourable prognosis for AID-positive IgG4-RD patients. CONCLUSIONS: 14.8% of IgG4-RD patients had AID family history, with younger age of disease onset age and higher frequency of ANA positivity in AID-positive group, indicating that IgG4-RD may share genetic background with other AID.
引用
- Sun R, Liu Z, Lu H, et al. Potential impact of autoimmune diseases family history in IgG4-related disease: a retrospective cohort study. RMD Open. 2023. PMID: 36759004. doi:10.1136/rmdopen-2022-002865
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。